Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease
Gaucher disease (GD) is caused by deficiency of the lysosomal membrane enzyme glucocerebrosidase (GCase) and the subsequent accumulation of its substrate, glucosylceramide (GC). Mostly missense mutations of the glucocerebrosidase gene (GBA) cause GCase misfolding and inhibition of proper lysosomal t...
Guardado en:
Autores principales: | Margarita M. Ivanova, Julia Dao, Neil Kasaci, Benjamin Adewale, Shaista Nazari, Lauren Noll, Jacqueline Fikry, Armaghan Hafez Sanati, Ozlem Goker-Alpan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ae526a440ac4cba991bf36e1ee47610 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease.
por: Margarita M Ivanova, et al.
Publicado: (2021) -
Literature Review: Dental Aspects in Gaucher Disease
por: Santos,Elza Maria Carneiro Mendes Ferreira dos, et al.
Publicado: (2018) -
Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia
por: Irene Motta, et al.
Publicado: (2021) -
Review of the safety and efficacy of imiglucerase treatment of Gaucher disease
por: Deborah Elstein, et al.
Publicado: (2009) -
Gaucher Disease Type I: A Case Report
por: Nikolova D., et al.
Publicado: (2020)